XML 25 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from (used in) operating activities:      
Net income $ 200.5 $ 89.9 $ 0.2
Less: Loss from discontinued operations, net of tax (1.3) (54.8) (19.6)
Income from continuing operations 201.8 144.7 19.8
Adjustments to reconcile income from continuing operations to net cash from (used in) operating activities      
Loss on divestiture of asbestos-related assets and liabilities 0.0 0.0 73.9
Special charges, net 3.6 0.8 0.4
(Gain) loss on change in fair value of equity security 4.2 (3.6) 3.0
Loss on amendment/refinancing of senior credit agreement 0.0 0.0 1.1
Impairment of goodwill and intangible assets 0.0 0.0 13.4
Deferred and other income taxes (15.1) (25.2) (21.4)
Depreciation and amortization 91.6 63.2 46.4
Pension and other employee benefits 15.4 22.0 3.4
Long-term incentive compensation 15.0 13.4 10.9
Other, net (8.7) (5.9) 0.5
Contribution to divest asbestos-related assets and liabilities 0.0 0.0 (138.8)
Changes in operating assets and liabilities, net of effects from acquisitions and divestitures:      
Accounts receivable and other assets 2.1 30.6 (0.3)
Inventories 9.1 (3.1) (53.4)
Accounts payable, accrued expenses and other (4.3) 7.0 (73.7)
Cash spending on restructuring actions (1.6) (0.1) (0.4)
Net cash from (used in) continuing operations 313.1 243.8 (115.2)
Net cash used in discontinued operations (27.2) (35.3) (21.6)
Net cash from (used in) operating activities 285.9 208.5 (136.8)
Cash flows from (used in) investing activities:      
Proceeds/borrowings related to company-owned life insurance policies, net 41.9 0.7 3.7
Proceeds from asset sales and other, net 3.6 0.0 0.0
Business acquisitions, net of cash acquired (292.0) (547.0) (40.0)
Capital expenditures (38.0) (23.9) (15.9)
Net cash used in continuing operations (284.5) (570.2) (52.2)
Net cash used in discontinued operations 0.0 0.0 (13.9)
Net cash used in investing activities (284.5) (570.2) (66.1)
Cash flows from (used in) financing activities:      
Borrowings under senior credit facilities 384.8 869.1 245.0
Repayments under senior credit facilities (321.8) (572.5) (243.7)
Borrowings under trade receivables agreement 272.0 178.0 0.0
Repayments under trade receivables agreement (279.0) (162.0) 0.0
Net repayments under other financing arrangements (1.2) (0.4) (0.8)
Payment of contingent consideration 0.0 0.0 (1.3)
Minimum withholdings paid on behalf of employees for net share settlements, net of proceeds from the exercise of employee stock options and other 0.9 (1.3) (3.5)
Repurchases of common stock 0.0 0.0 (33.7)
Financing fees paid (2.6) (1.3) (1.9)
Net cash from (used in) continuing operations 53.1 309.6 (39.9)
Net cash from discontinued operations 0.0 0.0 1.0
Net cash from (used in) financing activities 53.1 309.6 (38.9)
Change in cash and equivalents due to changes in foreign currency exchange rates 2.0 (0.1) 2.9
Net change in cash and equivalents 56.5 (52.2) (238.9)
Consolidated cash and equivalents, beginning of period 104.9 157.1 396.0
Consolidated cash and equivalents, end of period 161.4 104.9 157.1
Supplemental disclosure of cash flow information:      
Interest paid 43.4 25.6 6.5
Income tax payments, net 43.5 58.4 59.6
Non-cash investing and financing activity:      
Debt assumed $ 1.1 $ 0.3 $ 0.0